Clinical Trial Results: AFPᶜ³³²T in Advanced HCC [Phase 1]

View source ↗

Summary

Phase 1 clinical trial results for AFPc33 in advanced hepatocellular carcinoma and AFP-expressing tumors have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• AFP³³²T (AFPc33)

Snippet

Sponsor: Adaptimmune | Conditions: Hepatocellular Cancer, AFP Expressing Tumors | Phase 1 | Status: COMPLETED | Results posted: 2026-06-17